ibsa france

IBSA Pharma S.A.S is the French subsidiary of IBSA, an international pharmaceutical group based in Switzerland. Created in 1987 under the Laboratoires Genevrier entity in the heart of Sophia-Antipolis, the first European technology park, IBSA Pharma has developed in 8 areas of specialization and provides patients and healthcare professionals with more than 100 pharmaceutical products, all manufactured in Europe according to the highest quality standards. Focused on innovation and driven by the desire to bring therapeutic alternatives to as many people as possible, the IBSA group is committed to improving the quality of life of patients by offering them health products in their best galenic form, for a proven and increased efficiency. IBSA Pharma is based on the 4 ethical and sustainable pillars of the group: #person, #innovation, # quality and # responsibility.

sandoz canada

Chez Sandoz Canada, nous contribuons aux efforts de la société pour répondre aux besoins croissants en matière de soins de santé en proposant des médicaments de haute qualité et abordables. Notre portfolio de plus de 260 molécules couvre les principaux domaines thérapeutiques et notre influence au Canada est telle que nous sommes le premier fournisseur de médicaments génériques des hôpitaux. Nos nouveaux secteurs d’activités concernant les biosimilaires et les produits aux consommateurs démontrent notre capacité d’adaptation face à des marchés en constante évolution. Nous nous efforçons aussi d’offrir à nos employés un environnement de travail enrichissant et nous sommes toujours à la recherche de nouveaux talents aux expériences et aux compétences diversifiées, ainsi que de nouvelles manières de penser afin de favoriser l’innovation. Si vous désirez porter à notre attention un effet indésirable envers un de nos produits, écrivez-nous à drug.safety@novartis.com. Nous réservons le droit de supprimer les commentaires jugés discriminatoires, abusifs ou inappropriés. www.sandoz.ca / At Sandoz Canada we contribute to society’s ability to support growing healthcare needs by providing high-quality, affordable medicines. Our portfolio of over 260 molecules covers all major therapeutic areas and our impact in Canada is such that we’re the #1 supplier of generic drugs to hospitals. Our new biosimilars and consumer products business segments demonstrate our ability to adapt to ever-changing markets. We also strive to provide our employees with an enriching work environment and we’re always looking for new talent with diversified backgrounds, experiences, and new ways of thinking to help foster innovation. If you would like to report an adverse event to one of our products, please write to us at drug.safety@novartis.com. We reserve the right to delete comments we deem to be discriminatory, abusive or inappropriate. www.sandoz.ca

Salus Group / Skupina Salus

Salus Group is the leading commercialization and distribution partner of choice for Healthcare and Biotech companies seeking to expand their presence and drive business growth in 17 countries across Central Eastern and South Eastern Europe. Our mission is to address the unmet medical needs in the CEE/SEE region by bringing innovative medical treatments to patients. With over 50 years of experience and a deep understanding of the regional market, we leverage our extensive network to deliver successful access commercialization results. At Salus Group, we are passionate about putting our customers and patients first, and we strive to provide exceptional service and support to meet their needs. Our comprehensive range of services includes market access, medical, promotion, sales, regulatory, pharmacovigilance, NPP, distribution, warehousing - all coordinated from one location in EU Slovenia, Salus' HQ. With a focus on scientific expertise and a commitment to excellence, we are dedicated to shaping the future of healthcare in the CEE region. Contact us: Email: razvoj@salus.si Telephone: +386 1 589 10 00 Website: www.salus.si

Costello Medical

At Costello Medical, we enjoy building lasting partnerships in the healthcare sector by providing exceptional service. Our vision is to be a leading global partner consistently striving for meaningful and outstanding contributions that improve people’s health and lives. Our experts support the healthcare sector in the analysis, interpretation, and communication of clinical and health economic data; our service offerings include evidence development, statistics, health economics, HTA, real-world evidence, market access, medical affairs, publications, and design. We are one of the most established independent agencies delivering medical communications and health economic services. We have grown organically since foundation in 2008 to a team of over 350 based in Cambridge, London, Manchester and Bristol in the UK and internationally in Singapore, China and the US. Our talented team has experience with a variety of leading pharmaceutical and device companies across an extensive range of therapy areas and geographies, including Europe, Asia Pacific, and North America. We are proud to have achieved a 3-star accreditation with Best Companies™ for a sixth consecutive year, and have achieved B Corp certification, showing that we meet the highest standards of verified social and environmental performance.

Eurofins BioPharma Product Testing Netherlands

Eurofins BioPharma Product Testing Netherlands is part of the Eurofins’ international network of harmonised product testing laboratories. We have over 20 years of experience serving the (bio)pharmaceutical and medical device industry with laboratory, manufacturing and consultancy services. Our laboratories offer a broad range of methodologies under GMP authorisation, GLP, and ISO 17025, 9001, and 13485 accreditations. Our services are fully comprehensive and include testing of drug substances, final products, intermediates, starting raw materials for both small molecule and biologics drug products, and medical devices. We can support our customers with developing test methods from scratch or transfer client methods under regulatory compliant conditions. Aside from testing, we have multiple aseptic manufacturing units for small-scale compounding and fill & finish activities, including labelling and packaging services. Leveraging our international network of Eurofins companies, we can offer our customers the complete testing package for their product while ensuring regulatory compliance.